112 related articles for article (PubMed ID: 9184858)
1. Efficacy of intra-arterial norcantharidin in suppressing tumour 14C-labelled glucose oxidative metabolism in rat Morris hepatoma.
Mack P; Ha XF; Cheng LY
HPB Surg; 1996; 10(2):65-72. PubMed ID: 9184858
[TBL] [Abstract][Full Text] [Related]
2. The thermal activity of normal and malignant tissues. Microcalorimetric response of liver cancer to hepatic artery ligation, cryosurgery, adriamycin and norcantharidin.
Mack P; Cheng LY
HPB Surg; 1998; 11(2):75-86. PubMed ID: 9893237
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatoma with liposome-encapsulated adriamycin administered into hepatic artery of rats.
Sun DS; Chen JH; Ling R; Yao Q; Wang L; Ma Z; Li Y
World J Gastroenterol; 2006 Aug; 12(29):4741-4. PubMed ID: 16937449
[TBL] [Abstract][Full Text] [Related]
4. Body distribution of nanoparticle-containing adriamycin injected into the hepatic artery of hepatoma-bearing rats.
Chen JH; Wang L; Ling R; Li Y; Wang Z; Yao Q; Ma Z
Dig Dis Sci; 2004 Aug; 49(7-8):1170-3. PubMed ID: 15387341
[TBL] [Abstract][Full Text] [Related]
5. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Jiang Z; Chi J; Han B; Liu W
Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery ligation and adriamycin infusion chemotherapy for hepatoma.
Lee YT; Irwin L
Cancer; 1978 Apr; 41(4):1249-55. PubMed ID: 205338
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery.
Chen JH; Ling R; Yao Q; Wang L; Ma Z; Li Y; Wang Z; Xu H
World J Gastroenterol; 2004 Jul; 10(13):1989-91. PubMed ID: 15222053
[TBL] [Abstract][Full Text] [Related]
8. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival.
Yang EB; Tang WY; Zhang K; Cheng LY; Mack PO
Cancer Lett; 1997 Jul; 117(1):93-8. PubMed ID: 9233837
[TBL] [Abstract][Full Text] [Related]
10. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of anti-tumor effect of adriamycin by verapamil in a hepatic arterial infusion in the rats: preliminary report].
Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Suzuki H; Okui K
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):226. PubMed ID: 2038296
[No Abstract] [Full Text] [Related]
12. [Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism].
Li Q; Fan ZZ; Li XQ; Liu XH; Sun J; Gu W; Heng P; Gao H
Zhong Xi Yi Jie He Xue Bao; 2006 Jul; 4(4):378-83. PubMed ID: 16834975
[TBL] [Abstract][Full Text] [Related]
13. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
Averbach A; Stuart OA; Chang D; Sugarbaker PH
Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.
Wen X; Reynolds L; Mulik RS; Kim SY; Van Treuren T; Nguyen LH; Zhu H; Corbin IR
Gastroenterology; 2016 Feb; 150(2):488-98. PubMed ID: 26484708
[TBL] [Abstract][Full Text] [Related]
15. The effect of hepatic progenitor cells on experimental hepatocellular carcinoma in the regenerating liver.
Shi JH; Scholz H; Huitfeldt HS; Line PD
Scand J Gastroenterol; 2014 Jan; 49(1):99-108. PubMed ID: 24188385
[TBL] [Abstract][Full Text] [Related]
16. O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.
Yamaura G; Yoshioka T; Fukuda H; Yamaguchi K; Suzuki M; Furumoto S; Iwata R; Ishioka C
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1134-9. PubMed ID: 16779557
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic artery and portal vein infusion of adriamycin in experimental liver metastasis].
Kuroda K; Horita Y; Sakane M; Okumoto S; Katoh M; Saitoh Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2859-62. PubMed ID: 2782893
[TBL] [Abstract][Full Text] [Related]
19. Influence of 2-deoxy-D-glucose and arterial ischaemia on glucose oxidation and growth of liver cancer in the rat.
Mack P; Ahrén B; Jeppsson B; Kan Z; Bengmark S
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1433-7. PubMed ID: 3181267
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model.
Okada M; Kudo S; Miyazaki O; Saino T; Ekimoto H; Iguchi H; Hirano S; Kuboki H; Kadosawa H; Takeuchi T
Br J Cancer; 1995 Mar; 71(3):518-24. PubMed ID: 7880733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
